Silibinin Inhibits Proliferation, Induces Apoptosis and Causes Cell Cycle Arrest in Human Gastric Cancer MGC803 Cells Via STAT3 Pathway Inhibition
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Silibinin Inhibits Proliferation, Induces Apoptosis and Causes Cell Cycle Arrest in Human Gastric Cancer MGC803 Cells Via STAT3 Pathway Inhibition
Authors
Keywords
-
Journal
Asian Pacific Journal of Cancer Prevention
Volume 15, Issue 16, Pages 6791-6798
Publisher
Asian Pacific Organization for Cancer Prevention
Online
2014-11-06
DOI
10.7314/apjcp.2014.15.16.6791
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery, Synthesis, and Evaluation of Small-Molecule Signal Transducer and Activator of Transcription 3 Inhibitors
- (2015) Zhi-Bing Shi et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Inhibition of Leptin and Leptin Receptor Gene Expression by Silibinin-Curcumin Combination
- (2014) Kazem Nejati-Koshki et al. Asian Pacific Journal of Cancer Prevention
- Effects of Celecoxib on Cycle Kinetics of Gastric Cancer Cells and Protein Expression of Cytochrome C and Caspase-9
- (2013) Yu-Jie Wang et al. Asian Pacific Journal of Cancer Prevention
- Curcumin and Silibinin Inhibit Telomerase Expression in T47D Human Breast Cancer Cells
- (2013) Marzieh Nasiri et al. Asian Pacific Journal of Cancer Prevention
- Autophagy Inhibition Sensitizes Cisplatin Cytotoxicity in Human Gastric Cancer Cell Line Sgc7901
- (2013) Hui-Qing Zhang et al. Asian Pacific Journal of Cancer Prevention
- Palliative Treatment and the Role of Surgical Resection in Gastric Cancer
- (2013) Martin S. Karpeh DIGESTIVE SURGERY
- Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells
- (2013) Sílvia Cufí et al. FOOD AND CHEMICAL TOXICOLOGY
- Multitargeting and Antimetastatic Potentials of Silibinin in Human HepG-2 and PLC/PRF/5 Hepatoma Cells
- (2013) Reza Ghasemi et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Chemopreventive and Anti-Cancer Efficacy of Silibinin Against Growth and Progression of Lung Cancer
- (2013) Samiha Mateen et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Resveratrol Induces Cell Cycle Arrest and Apoptosis in Malignant NK Cells via JAK2/STAT3 Pathway Inhibition
- (2013) Ly Quoc Trung et al. PLoS One
- Docetaxel, Cisplatin and Fluorouracil (DCF) Regimen Compared with Non-Taxane-Containing Palliative Chemotherapy for Gastric Carcinoma: A Systematic Review and Meta-Analysis
- (2013) Xiao-Long Chen et al. PLoS One
- B Cells Promote Tumor Progression via STAT3 Regulated-Angiogenesis
- (2013) Chunmei Yang et al. PLoS One
- Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation
- (2012) Dong-bo Liu et al. ACTA PHARMACOLOGICA SINICA
- Silibinin – A Promising New Treatment for Cancer
- (2012) Catherine Wing Ying Cheung et al. Anti-Cancer Agents in Medicinal Chemistry
- Knockdown of a Proliferation-inducing Ligand (PRIL) Suppresses the Proliferation of Gastric Cancer Cells
- (2012) Jiu-Wei Cui et al. Asian Pacific Journal of Cancer Prevention
- Exogenous Morphine Inhibits Human Gastric Cancer MGC-803 Cell Growth by Cell Cycle Arrest and Apoptosis Induction
- (2012) Yi Qin et al. Asian Pacific Journal of Cancer Prevention
- Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression
- (2012) Kai-Wen Hsu et al. CARCINOGENESIS
- Anticancer action of garcinol in vitro and in vivo is in part mediated through inhibition of STAT-3 signaling
- (2012) A. Ahmad et al. CARCINOGENESIS
- Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells
- (2012) Wenyan Lu et al. CELLULAR SIGNALLING
- Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells
- (2012) Samiha Mateen et al. Epigenetics
- Targeting STAT3 in gastric cancer
- (2012) Andrew S Giraud et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The Immunohistochemical Expression of STAT3, Bcl-xL, and MMP-2 Proteins in Colon Adenoma and Adenocarcinoma
- (2012) Seung Woo Lee et al. Gut and Liver
- Silibinin Inhibits the Invasion of IL-6-Stimulated Colon Cancer Cells via Selective JNK/AP-1/MMP-2 Modulation in Vitro
- (2012) Chiu-Mei Lin et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Constitutive activation of STAT3 is predictive of poor prognosis in human gastric cancer
- (2012) Hua Xiong et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (SOCS-1) protein in prostate cancer
- (2012) Neha Singh et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- In Vivo Induction of Apoptosis by Fucoxanthin, a Marine Carotenoid, Associated with Down-Regulating STAT3/EGFR Signaling in Sarcoma 180 (S180) Xenografts-Bearing Mice
- (2012) Jun Wang et al. Marine Drugs
- Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
- (2012) X. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SPARC expression induces cell cycle arrest via STAT3 signaling pathway in medulloblastoma cells
- (2011) Chandramu Chetty et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines
- (2011) Stacey L Fossey et al. BMC CANCER
- Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells
- (2011) Shuling Huang et al. CANCER LETTERS
- STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers
- (2011) Teppei Morikawa et al. CLINICAL CANCER RESEARCH
- Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer
- (2011) Janos Feher et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- The cell cycle and cancer
- (2011) Gareth H Williams et al. JOURNAL OF PATHOLOGY
- Spatiotemporal regulations of Wee1 at the G2/M transition
- (2011) Hirohisa Masuda et al. MOLECULAR BIOLOGY OF THE CELL
- Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion
- (2011) Meng Sun et al. PROSTATE
- Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer
- (2010) Gagan Deep et al. CANCER AND METASTASIS REVIEWS
- Chemoprevention of Intestinal Tumorigenesis in APCmin/+ Mice by Silibinin
- (2010) S. Rajamanickam et al. CANCER RESEARCH
- Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to Mitosis
- (2010) Olivier Gavet et al. DEVELOPMENTAL CELL
- Targeting silibinin in the antiproliferative pathway
- (2010) Lei Li et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression
- (2009) Kai-jie Wu et al. ACTA PHARMACOLOGICA SINICA
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
- (2009) M. H. Kang et al. CLINICAL CANCER RESEARCH
- STAT3 as a Central Regulator of Tumor Metastases
- (2009) Eswaran Devarajan et al. CURRENT MOLECULAR MEDICINE
- Silibinin inhibits translation initiation: implications for anticancer therapy
- (2009) C.-J. Lin et al. MOLECULAR CANCER THERAPEUTICS
- Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft
- (2009) M. Kaur et al. MOLECULAR CANCER THERAPEUTICS
- Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
- (2008) A. C. Mita et al. CLINICAL CANCER RESEARCH
- Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: Relationship with silibinin levels
- (2008) Richard D. Verschoyle et al. EUROPEAN JOURNAL OF CANCER
- Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) - gastrointestinal cancer group
- (2008) Eric Van Cutsem et al. EUROPEAN JOURNAL OF CANCER
- Stat3 mediates myeloid cell–dependent tumor angiogenesis in mice
- (2008) Maciej Kujawski et al. JOURNAL OF CLINICAL INVESTIGATION
- STAT3 expression in gastric cancer indicates a poor prognosis
- (2008) Dae-Young Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Screening for gastric cancer in Asia: current evidence and practice
- (2008) Wai K Leung et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now